Association of Vitamin D levels with outcome in patients with melanoma after adjustment for C-reactive protein

Journal of Clinical Oncology

Volumn 34, Issue 15, 2016, Pages 1741-1747

  Fang, Shenying ^a   Sui, Dawen ^a   Wang, Yuling ^a   Liu, Huey ^a   Chiang, Yi Ju ^a   Ross, Merrick I ^a   Gershenwald, Jeffrey E ^a   Cormier, Janice N ^a   Royal, Richard E ^a   Lucci, Anthony ^a   Wargo, Jennifer ^a   Hu, Mimi I ^a   Gardner, Julie M ^a   Reveille, John D ^b   Bassett, Roland L ^a   Wei, Qingyi ^c   Amos, Christopher I ^d   Lee, Jeffrey E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DARTMOUTH COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; VITAMIN D; 25-HYDROXYVITAMIN D;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER SPECIFIC SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; CUTANEOUS MELANOMA; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLASMA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR VOLUME; UNIVARIATE ANALYSIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; MELANOMA; MORTALITY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; DISEASE-FREE SURVIVAL; HUMANS; MELANOMA; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; VITAMIN D;

EID: 84969522613     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.64.1357     Document Type: Article

References (35)

1. Al Mheid I, Patel RS, Tangpricha V, et al: Vitamin D and cardiovascular disease: Is the evidence solid? Eur Heart J 34:3691-3698, 2013
2. Kienreich K, Tomaschitz A, Verheyen N, et al: Vitamin D and cardiovascular disease. Nutrients 5: 3005-3021, 2013
3. Pludowski P, Holick MF, Pilz S, et al: Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality: A review of recent evidence. Autoimmun Rev 12:976-989, 2013
4. Vuolo L, Di Somma C, Faggiano A, et al: Vitamin D and cancer. Front Endocrinol (Lausanne) 3: 58, 2012
5. Reichrath J, Rech M, Moeini M, et al: In vitro comparison of the vitamin D endocrine system in 1, 25(OH)2D3-responsive and -resistant melanoma cells. Cancer Biol Ther 6:48-55, 2007
6. Eisman JA, Barkla DH, Tutton PJ: Suppression of in vivo growth of human cancer solid tumor xenografts by 1, 25-dihydroxyvitamin D3. Cancer Res 47: 21-25, 1987
7. Reichrath J, Rass K: Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: An update. Adv Exp Med Biol 810:208-233, 2014
8. Major JM, Kiruthu C, Weinstein SJ, et al: Prediagnostic circulating vitamin D and risk of melanoma in men. PLoS One 7:e35112, 2012
9. Meyskens FL Jr, Farmer PJ, Anton-Culver H: Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev 14:293, 2005
10. Millen AE, Tucker MA, Hartge P, et al: Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev 13:1042-1051, 2004
11. Veierød MB, Thelle DS, Laake P: Diet and risk of cutaneous malignant melanoma: A prospective study of 50, 757 Norwegian men and women. Int J Cancer 71:600-604, 1997
12. Nürnberg B, Gräber S, Gärtner B, et al: Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients. Anticancer Res 29:3669-3674, 2009
13. Newton-Bishop JA, Beswick S, Randerson- Moor J, et al: Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma. J Clin Oncol 27:5439-5444, 2009
14. Berwick M, Erdei EO: Vitamin D and melanoma incidence and mortality. Pigment Cell Melanoma Res 26:9-15, 2013
15. Field S, Davies J, Bishop DT, et al: Vitamin D and melanoma. Dermatoendocrinol 5:121-129, 2013
16. Chang YM, Barrett JH, Bishop DT, et al: Sun exposure and melanoma risk at different latitudes: A pooled analysis of 5, 700 cases and 7, 216 controls. Int J Epidemiol 38:814-830, 2009
17. Findeisen P, Zapatka M, Peccerella T, et al: Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling. J Clin Oncol 27:2199-2208, 2009
18. Fang S, Wang Y, Sui D, et al: C-reactive protein as a marker of melanoma progression. J Clin Oncol 33:1389-1396, 2015
19. Ghashut RA, Talwar D, Kinsella J, et al: The effect of the systemic inflammatory response on plasma vitamin 25 (OH) D concentrations adjusted for albumin. PLoS One 9:e92614, 2014
20. Balch CM, Gershenwald JE, Soong SJ, et al: Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199-6206, 2009
21. Kelly JL, Salles G, Goldman B, et al: Low serum vitamin D levels are associated with inferior survival in follicular lymphoma: A prospective evaluation in SWOG and LYSA studies. J Clin Oncol 33: 1482-1490, 2015
22. Tsilidis KK, Branchini C, Guallar E, et al: Creactive protein and colorectal cancer risk: A systematic review of prospective studies. Int J Cancer 123:1133-1140, 2008
23. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al: Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18-28, 2006
24. Holick MF, Chen TC: Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 87:1080S-1086S, 2008
25. The R Project for Statistical Computing. https://www.r-project.org/
26. Zhang X, Loberiza FR, Klein JP, et al: A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. Comput Methods Programs Biomed 88:95-101, 2007
27. Asgari MM, Maruti SS, Kushi LH, et al: A cohort study of vitamin D intake and melanoma risk. J Invest Dermatol 129:1675-1680, 2009
28. Hollis BW: Measuring 25-hydroxyvitamin D in a clinical environment: Challenges and needs. Am J Clin Nutr 88:507S-510S, 2008
29. Duncan A, Talwar D, McMillan DC, et al: Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. Am J Clin Nutr 95:64-71, 2012
30. Conway FJ, McMillan DC: Plasma vitamin D concentration and survival in colorectal cancer: Potential confounding by the systemic inflammatory response. J Clin Oncol 33:224, 2015
31. Zgaga L, Theodoratou E, Farrington SM, et al: Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. J Clin Oncol 32:2430-2439, 2014
32. Tang JY, Fu T, Leblanc E, et al: Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: Post hoc analyses of the women's health initiative randomized controlled trial. J Clin Oncol 29:3078-3084, 2011
33. Garland CF, French CB, Baggerly LL, et al: Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res 31:607-611, 2011
34. Sullivan SS, Rosen CJ, Halteman WA, et al: Adolescent girls in Maine are at risk for vitamin D insufficiency. J Am Diet Assoc 105:971-974, 2005
35. Saneei P, Salehi-Abargouei A, Esmaillzadeh A: Serum 25-hydroxy vitamin D levels in relation to body mass index: A systematic review and meta-analysis. Obes Rev 14:393-404, 2013